Cannabis and HU-331
Browse the latest research linking medical marijuana / medicinal cannabis and HU-331 (a cannabinoid (synthetic))

HU-331 is a quinone anticarcinogenic drug synthesized from cannabidiol, a cannabinoid in the Cannabis sativa plant. [Wikipedia]
Click on a study title below to open a new tab with full article, or click on a compound to see it's full list of research.
Compounds Topics Title Date
HU-331 cancer in vitro,mice HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor. Jan 2007
A new anticancer quinone (HU-331) was synthesized from cannabidiol. It shows significant high efficacy against human cancer cell lines in vitro and against in vivo tumor grafts in nude mice.
HU-331 cancer in mice via experiment A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo study. Aug 2007
In vivo, HU-331 was more active and less toxic than doxorubicin and thus it has a high potential for development as a new anticancer drug.